1. From the Centre de Recherche des Cordeliers, Physiopathology of Ocular Diseases: Therapeutic Innovations, UMR S 872, Universite´ Paris Descartes, Paris, France; the
2. From the Centre de Recherche des Cordeliers, Physiopathology of Ocular Diseases: Therapeutic Innovations, UMR S 872, Universite´ Paris Descartes, Paris, France; the2Rothschild Foundation, Paris, France; the
3. From the Centre de Recherche des Cordeliers, Physiopathology of Ocular Diseases: Therapeutic Innovations, UMR S 872, Universite´ Paris Descartes, Paris, France; the3Department of Ophthalmology, Ho^tel-Dieu Paris, Paris, France;
4. Steba Biotech, Rehovot, Israel; and the
5. Weizmann Institute of Science, Rehovot, Israel.
6. From the Centre de Recherche des Cordeliers, Physiopathology of Ocular Diseases: Therapeutic Innovations, UMR S 872, Universite´ Paris Descartes, Paris, France; the2Rothschild Foundation, Paris, France; the3Department of Ophthalmology, Ho^tel-Dieu Paris,